You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial.
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, November 2015
|
| DOI | 10.1186/2051-1426-3-s2-o11 |
| Authors |
Nabil Ahmed, Vita Brawley, Meenakshi Hegde, Kevin Bielamowicz, Amanda Wakefield, Alexia Ghazi, Aidin Ashoori, Oumar Diouf, Claudia Gerken, Daniel Landi, Mamta Kalra, Zhongzhen Yi, Cliona Rooney, Gianpietro Dotti, Adrian Gee, Helen Heslop, Stephen Gottschalk, Suzanne Powell, Robert Grossman, Winfried Wels, Yzonne Kew, David Baskin, Jonathan Zhang, Pamela New, John Hicks |
Mendeley readers
The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 38 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 6 | 16% |
| Student > Bachelor | 6 | 16% |
| Student > Ph. D. Student | 5 | 13% |
| Other | 4 | 11% |
| Student > Master | 3 | 8% |
| Other | 8 | 21% |
| Unknown | 6 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 9 | 24% |
| Medicine and Dentistry | 7 | 18% |
| Immunology and Microbiology | 6 | 16% |
| Agricultural and Biological Sciences | 4 | 11% |
| Arts and Humanities | 1 | 3% |
| Other | 3 | 8% |
| Unknown | 8 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2018.
All research outputs
#6,598,118
of 25,374,917 outputs
Outputs from Journal for Immunotherapy of Cancer
#1,594
of 3,421 outputs
Outputs of similar age
#77,158
of 296,796 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#24
of 98 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 3,421 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 296,796 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.